Inappetence Clinical Trial
Official title:
Clinical Study Phase III, Randomized, Double-blind, Prospective and Comparative to Evaluate the Efficacy and Tolerability of Using APETIVITON BC Compared to Petivit BC in Appetite Stimulate.
Clinical study phase III, randomized, double-blind, prospective, comparative non-inferiority to evaluate the efficacy and tolerability of using APETIVITON BC compared to Petivit BC in appetite stimulate in children, adults and elderly.
Clinical trial phase III, randomized, double-blind, prospective, comparative non-inferiority
to evaluate the efficacy and tolerability of using APETIVITON BC compared to Petivit BC
stimulation of appetite in children, adults and elderly. A total of 150 patients,
distributed as follows:
25 patients treated children Apetiviton BC,25 patients treated children Petivit BC, (2-6
years).
25 adult patients treated with Apetiviton BC,25 adult patients treated with Petivit BC,
(18-50 years.
25 elderly patients treated with Apetiviton BC,25 elderly patients treated with Petivit BC.
(60-80 years.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment